F1000Research flies the nest - F1000 Blogs

"I am delighted to announce today that F1000 Research Ltd has been acquired by Taylor & Francis Group (part of Informa plc). This is a hugely exciting opportunity for us. For a start, it will expedite our growth through the greater financial support and resources of a very large established organisation with extensive geographical and disciplinary reach. But most exciting to me, it will give us the opportunity to directly influence one of the ‘Big 4’ publishers to support the transition towards more open and collaborative ways of working, enabled though new approaches to scholarly publishing.   

It will be no surprise to many that F1000 Research is now transferring to a new owner. Our founder, Vitek Tracz has an impressive track record of nurturing ideas through start-up companies, and taking them to a level where they are ready to fly the nest. We will be following in the footsteps of many of his companies that have gone on to exciting and successful onward lives in the hands of others including BioMed Central (where Vitek initiated the Open Access movement in collaboration with PubMed Central), Current Opinions series, Current Biology, Current Drugs, Current Patents, IDdb3, Telmap, The Scientist, and many more.

Since F1000 Research’s conception, Vitek has been adamant that he would only ever sell F1000 Research to an organisation that he is convinced is fully committed to not only maintaining our vision and supporting us to scale up but also to ultimately transform the whole industry over time. Both Vitek and I feel confident that we have found such an organisation in Taylor & Francis, its CEO Annie Callanan and her executive leadership team, and I am very excited to continue to lead F1000 Research in this next phase...."